A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
Rothenberg ML; Moore MJ; Cripps MC; Andersen JS; Portenoy RK; Burris HA 3rd; Green MR; Tarassoff PG; Brown TD; Casper ES; Storniolo AM; Von Hoff DD; Annals Of Oncology: Official Journal Of The European Society For Medical Oncology / ESMO, 1996, vol. 7, issue 4, p 347, ISSN 09237534. ISBN 09237534.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef